开发和验证一个时间依赖的诺米克图,用于预测在耐药结核病的线索利德治疗期间的血液毒性风险
Wenqiang Zhou1, Hui Zhu2, Zhongquan Liu2
1Department of Infectious Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Pharmacotherapy
|February 9, 2026
概括
一个新的诺米图预测了用linezolid治疗耐药结核病 (DR-TB) 患者的血液毒性. 它整合了药物度和临床因素,用于早期风险识别和干预.
科学领域:
- 药理学和毒理学 药理学和毒理学
- 传染性疾病 传染性疾病
- 血液学 血液学 血液学
背景情况:
- 利尼佐利德对于治疗耐药结核病 (DR-TB) 是至关重要的.
- 血液毒性是linezolid治疗的常见和显著的副作用.
- 预测这种毒性对于患者管理至关重要.
研究的目的:
- 开发和验证一种依赖时间的诺米克图,用于预测在DR-TB患者中因线化物诱导的血液毒性.
- 确定血液毒性的关键预测因素,包括药物度和临床因素.
- 为了能够早期识别高风险患者,进行预防性干预.
主要方法:
- 201名DR-TB患者接受linezolid (600毫克/天) 的前性队列研究.
- 测量线化物最低度 (Cmin) 和相关的临床变量.
- 多变量考克斯回归和毒性概率在1,3,6个月的诺莫格拉姆构造,通过C指数和时间依赖的AUC来评估性能.
主要成果:
- 47.8%的患者经历了血液学不良事件 (贫血,白血病,血小板减少).
- 有意义的预测因素包括Cmin>2.08 mg/L,较低的基线白细胞,血红蛋白和肌素清除,以及初始治疗状态.
- 命名图表表现出良好的区分 (C指数=0.73) 和校准,时间依赖的AUC从0.74到0.80.
结论:
- 经过验证的纳米图集Cmin和基线临床因素可以识别具有高风险的DR-TB患者,他们可能患有linezolid诱导的血液毒性.
- 这种工具可以指导预防性干预,以减轻毒性.
- 在广泛临床实施之前,需要外部验证.
相关概念视频
In Vitro Drug Release Testing: Overview, Development and Validation
363
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
363
Drug Dependence
1.7K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.7K
Development of Antibiotic Resistance
1.5K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.5K
Drug Therapy
302
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
302
Reliability and Validity
14.1K
Reliability and validity are two important considerations that must be made with any type of data collection. Reliability refers to the ability to consistently produce a given result. In the context of psychological research, this would mean that any instruments or tools used to collect data do so in consistent, reproducible ways.
14.1K
Chronopharmacokinetics: Time-Dependent Pharmacokinetics
418
Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
418


